Boothbay Fund Management’s Precision BioSciences DTIL Stock Holding History

Boothbay Fund Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Buy	1,346,004 +279,954	+26%	+$1.97M	0.14%	150
2026 Q1	$5.86M	Hold	1,066,050	–	–	0.08%	274
2025 Q4	$4.43M	Buy	1,066,050 +887,515	+497%	+$5.04M	0.07%	323
2025 Q3	$986K	Sell	178,535 -21,465	-11%	-$103K	0.01%	844
2025 Q2	$840K	Hold	200,000	–	–	0.02%	742
2025 Q1	$954K	Buy	+200,000	New	+$1.02M	0.03%	651
2022 Q3	–	Sell	-856	Closed	-$41K	–	2323
2022 Q2	$41K	Buy	856 +483	+129%	+$28.4K	﹤0.01%	2093
2022 Q1	$34K	Buy	+373	New	+$50.7K	﹤0.01%	2215
2020 Q3	–	Sell	-1,992	Closed	-$498K	–	1085
2020 Q2	$498K	Buy	1,992 +1,562	+363%	+$342K	0.03%	576
2020 Q1	$78K	Sell	430 -12	-3%	-$3.14K	0.01%	752
2019 Q4	$184K	Sell	442 -225	-34%	-$70.7K	0.02%	719
2019 Q3	$168K	Sell	667 -649	-49%	-$211K	0.02%	664
2019 Q2	$523K	Buy	+1,316	New	+$530K	0.05%	399

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boothbay Fund Management's DTIL Position: Q2 2026 in Review

Boothbay Fund Management increased its Precision BioSciences (DTIL) stake by 26% in Q2 2026, buying an estimated $1.97M and bringing the position to 1,346,004 shares worth $10.6M. The position accounts for 0.14% of the portfolio, ranked #150.

Boothbay Fund Management first reported a position in DTIL in Q2 2019 and has held it in 13 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Boothbay Fund Management held 1,346,004 shares of Precision BioSciences worth $10.6M as of Q2 2026.
Boothbay Fund Management bought 279,954 Precision BioSciences shares in Q2 2026, an estimated $1.97M.
Precision BioSciences made up 0.14% of Boothbay Fund Management's portfolio in Q2 2026, its #150 holding.
Boothbay Fund Management first reported a position in Precision BioSciences in Q2 2019 and has held it in 13 quarters since.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.